Dinoprost

This classification denotes a prostaglandin analogue with the molecular formula C20H34O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B7IN85G1HY, chemically known as (5z,13e)-(15s)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate but generally known as dinoprost, which bears US NIH Compound Identifier 160. European Medicines Agency schedules Dinoprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07194MIG. The term DINOPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules dinoprost in its Anatomical Therapeutic Chemical (ATC) Classification. DINOPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dinoprost under HS 29375000 and SITC 54156. As of Q4 2014, DINOPROST remains the US FDA Preferred Term for this commodity. Dinoprost bears US NLM identifiers UMLS ID C0012471 and NCI Concept Code C65413. SMILES: OC1C(C(C(O)C1)/C=C/C(O)CCCCC)C/C=C/CCCC(=O)O.